Although a recent molecular docking study did not support the effective interaction between DPP4 and SARS-CoV-2 spike protein for virus entry [53], blockade of ACE2 and DPP4 has been proposed as a preventive strategy for COVID-19 [54,55] (Figure 3a). This evidence concerns the gene DPP4 and COVID-19.